KNOWLEDGE, ATTITUDE AND PRACTICES OF PHARMACOVIGILANCE AMONG THE HEALTH CARE PROFESSIONALS AT ISHAKA ADVENTIST HOSPITAL

  • Type: Project
  • Department: Pharmaceutical Science
  • Project ID: PHS0067
  • Access Fee: ₦5,000 ($14)
  • Pages: 43 Pages
  • Format: Microsoft Word
  • Views: 469
  • Report This work

For more Info, call us on
+234 8130 686 500
or
+234 8093 423 853

Table of Contents

Declarations •...••.•...•....•...•.••••.•••••.•.•.•.•••.•.•..•.•..........•.•.....................................................................•.•.....•...•• i

Approval •..•••.••.••.••.•.••.•••.•.•.•.••••••.••..•.•.•.•.•.•...•.••••.•.•.•.••.•.•.•.•.•.•.•..•..•.....•.•.•....•.•.•.•.•.•..••...•.•..•.•.•.•.•.....•.•.•.•.• ii

LIST OF ABBREVIATIONS ...................................................................................................................... iii

List of figu.res ............................................................................................................................................. viii

ABSTRACT ................................................................................................................................................. ix

CHAPTER ONE ......................................................................................................................................... 1

IN'TRODUCTION ........................................................................................................................................ 1

1.1Background •••.••.••......••.•.•.•••..••..•••.••..•.•.••.••.••.•..•.................................•.....•.•.•.••.....•••.•.•.•.•.•.•.•...........•..••• 1

1.2 Statement of the problem ........................................................................................................................ 3

1.3 Objectives ............................................................................................................................................... 3

1.3.1Main objective ...................................................................................................................................... 3

1.3 .2 Specific objectives ............................................................................................................................... 3

1.4 Research questions .................................................................................................................................. 4

1.5 Justification of the study ......................................................................................................................... 4

1.6 Conceptual framework. ........................................................................................................................... 5

CHAPTER TWO ........................................................................................................................................ 6

LITERA.TURE REVIEW . ............................................................................................................................ 6

2.0 Introduction ............................................................................................................................................. 6

2.1 Knowledge on Pharmacovigilance .......................................................................................................... 6

2.3 Attitude on Pharmacovigilance ............................................................................................................... 7

2.4 Practices on Pharmacovigilance .............................................................................................................. 8

CHAPTER 3 .............................................................................................................................................. 10

METHODOLOGY ..................................................................................................................................... 10

3.1 Study design .......................................................................................................................................... 10

3.2 Study area .............................................................................................................................................. 10

3.3 Selection criteria ................................................................................................................................... 10

3.3.1Inclusion criteria. ................................................................................................................................ 10

3.3.2 Exclusion criteria ........................................................................................................ ....................... 10

iv

3.4Study population and requirements ........................................................................................................ 10

3.5 Sample size ........................................................................................................................................... 11

3.6 Sampling technique ............................................................................................................................... 11

3.7 Data collection procedures .................................................................................................................... 11

3.8 Data management. ................................................................................................................................. 11

3.9 Data analysis ......................................................................................................................................... 12

3.10 Quality control. ................................................................................................................................... 12

3.11 Plans for dissemination of research .................................................................................................... 12

3 .12 Ethical considerations ......................................................................................................................... 13

3.13 Limitations to the study ...................................................................................................................... 13

CHAPTER FOUR ..................................................................................................................................... 14

RESULT PRESENTATION ....................................................................................................................... 14

4. 0 Introduction ........................................................................................................................................... 14

4.1 Social Demographic factors .................................................................................................................. 14

4.2 Knowledge on ADRs ............................................................................................................................ 15

4.2.1 Is ADR reporting a professional obligation? ..................................................................................... 16

4.2.2 Regulatory body responsible for ADR reporting ............................................................................... 17

4.3.1 Necessity of ADRs reporting ............................................................................................................. 18

4.3.2 Teaching Pharmacovigilance in detail to healthcare professionals .................................................... 19

4.3 .3 Article on prevention of ADRs .......................................................................................................... 19

4.3.4 Opinion on establishing ADR monitoring system in your hospital ................................................... 20

4.3 .5 Attitude based on socio demographic factors .................................................................................... 20

4.4 Practices on Pharmacovigilance among HCP at IAH ........................................................................... 21

CHAPTER FIVE ...................................................................................................................................... 22

DISCUSSION, CONCLUSION AND RECOMME:l'.TDA TIONS .............................................................. 22

5.1 Introduction ........................................................................................................................................... 22

5 .1 Discussion ............................................................................................................................................. 22

5. 4 Recommendations ................................................................................................................................. 24

REFERENCE .............................................................................................................................................. 25

ABSTRACT Background: In the sub-Saharan Africa 6.3% of hospital admissions were a direct result of adverse drug reactions and 4.5% admissions on medical ward in Kabale regional referral hospital were suspected to be due to adverse drug reactions. Thus this study was aimed at assessing the knowledge, attitude and practice ofPharmacovigilance among health workers at IAH. Methodology: A prospective cross sectional study was used and the study was carried out at Ishaka Adventist Hospital (IAH).Only health practitioners that consented were eligible to answer the questionnaires. A sample size of 100 pmticipants was used determined using Slovene's formula and data was collected with help of questionnaires. The collected data was entered into SPSS version 25. Analyzed and presented inform of tables and graphs. Results: Majority were 57(54.0%) females and 46(46%) were males. Majority 71(69.6%) were aged 18-30 years, 24(23.5%) were aged 31-40 years and 4(3.9%) were aged 41-50 years. Most, 74(72.5%) were nurses, and the least 2(2.0%) were mid wives. Majority 71(69.6%) defined Pharmacovigilance as the study of medicine whereas 19(18.6%) defined Pharmacovigilance as the detection, assessment, understanding and prevention of adverse effects. Conclusion: A low percentage of18.6% could defme Pharmacovigilance atld ADRs reporting was seen as an obligation of he3l.th workers. The National drug authority was a regulatory body responsible for ADRs monitoring. A large percentage of 60.8% had ever heard of ADRs and the main source of this information was television followed by radio. A high percentage of90.0% had good attitude towards rep01ting of ADRs since they thought reporting adverse drug reactions is necessary. More to this majority (95.0%) suggested teaching Pham1acovigilance in detail to healthcare professionals would be of great inlportance and 58.0% had ne·1er read any article on prevention of ADRs. Though majority (85.0%) of the health workers gave an opinion that ADR monitoring system would be of great inlportance. Majority (50.0%) of the health workers had ever experienced ADRs in their patients during their professional practice. 73.0% had never reported ADRs to the Pharmacovigilance center and health workers who had never reported ADRs to the Pharmacovigilance center 35.0% found difficult to decide whether an ADR had occurred or not and 45.0% said it was because of lack of finances to meet costs involved in reporting ADRs.

KNOWLEDGE, ATTITUDE AND PRACTICES OF PHARMACOVIGILANCE AMONG THE HEALTH CARE PROFESSIONALS AT ISHAKA ADVENTIST HOSPITAL
For more Info, call us on
+234 8130 686 500
or
+234 8093 423 853

Share This
  • Type: Project
  • Department: Pharmaceutical Science
  • Project ID: PHS0067
  • Access Fee: ₦5,000 ($14)
  • Pages: 43 Pages
  • Format: Microsoft Word
  • Views: 469
Payment Instruction
Bank payment for Nigerians, Make a payment of ₦ 5,000 to

Bank GTBANK
gtbank
Account Name Obiaks Business Venture
Account Number 0211074565

Bitcoin: Make a payment of 0.0005 to

Bitcoin(Btc)

btc wallet
Copy to clipboard Copy text

500
Leave a comment...

    Details

    Type Project
    Department Pharmaceutical Science
    Project ID PHS0067
    Fee ₦5,000 ($14)
    No of Pages 43 Pages
    Format Microsoft Word

    Related Works

    Table of Contents Declarations •...••.•...•....•...•.••••.•••••.•.•.•.•••.•.•..•.•..........•.•.....................................................................•.•.....•...•• i Approval... Continue Reading
    ABSTRACT Globally, 35 million people experience pain and suffering caused by old age or by lifelimiting conditions such as cancer, AIDS, and other chronic diseases. This study was purposely to examine the knowledge, attitude and practice of Health Workers about Palliative care at Ishaka Adventist Hospital, Bushenyi district. The study used a... Continue Reading
    TABLE OF CONTENTS DEDICATION.................................................................................................................................... III ACKNOWLEDGEMENT...................................................................................................................IV ABBREVIATIONS AND ACRONYMS... Continue Reading
    CHAPTER ONE: INTRODUCTION 1.1 Background Mental health is a crucial component of health that has not received appropriate visibility, policy attention and funding for many years, especially in low and middle income countries. In these countries, between 76% and 85% of people with severe mental disorders receive no treatment for these disorders The... Continue Reading
    Globally, it is estimated that nearly 500,000 women die annually from causes related to pregnancy and child birth and 99% of these deaths occur in developing countries. Male involvement in the antenatal care services clearly goes against prevailing gender norms in many places in Sub-Saharan Africa. Despite instituting programme targeted at... Continue Reading
    Abstract Condom use is of greater benefit to the youths. It is a tool that serves a great deal in prevention of HIV/AIDS and HIV related infections, so are other STD/STIs and unwanted pregnancies. Despite such benefits, youths do not use condoms. Therefore, this study aimed at assessing the KAP of youths attending KIU-TH towards condom use in... Continue Reading
    TABLE OF CONTENTS DECLARATION ............................................................................................................................. i APPROVAL.................................................................................................................................... ii DEDICATION... Continue Reading
    Abstract Each day thousands of healthcare workers (HCWs), around the world, suffer accidental occupational exposures during the course of their role of caring for patients. Occupational exposure to blood or other body fluids in health care settings constitutes significant risk of transmission of human immunodeficiency virus (HIV) and other... Continue Reading
    TABLE OFCONTENTS ABSTRACT............................................................................................................................ii COPYRIGHT........................................................................................................................iii... Continue Reading
    TABLE OF CONTENTS APPROVAL .............................................................................................................................................. ii ACKNOWLEDGEMENT......................................................................................................................... iii LIST OF... Continue Reading
    Call Us
    whatsappWhatsApp Us